España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Centene
CNC
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$57.68
-0.80
-1.37%
At close: -
$57.50
-0.18
-0.31%
After Hours: 7:29 PM EDT
Get Report
Comment
Centene (CNC) Forecast
News
Earnings
Centene (CNC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Centene (NYSE:CNC) Stock
Centene Stock (NYSE: CNC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
Benzinga Insights
Shares of health insurers are trading lower. ...
Benzinga Newsdesk
Friday, February 14, 2025
A Glimpse Into The Expert Outlook On Centene Through 9 Analysts
Benzinga Insights
Wells Fargo Maintains Overweight on Centene, ...
Benzinga Newsdesk
Monday, February 10, 2025
Humana Earnings On Deck: Investors Brace For Slower Growth Clip
Chandrima Sanyal
Tuesday, February 04, 2025
Here's How Much $100 Invested In Centene 20 Years Ago Would Be Worth Today
Benzinga Insights
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
Piero Cingari
Insurance Firm Centene Sees Q4 Revenue Boost, Sticks To Annual Forecast
Vandana Singh
(CNC) - Analyzing Centene's Short Interest
Benzinga Insights
Centene shares are trading lower. The company...
Benzinga Newsdesk
Centene Reaffirms FY2025 Adjusted EPS Of Grea...
Benzinga Newsdesk
Centene Reports FY2024 Health Benefits Ratio ...
Benzinga Newsdesk
Centene Q4 2024 Adj EPS $0.80 Beats $0.49 Est...
Benzinga Newsdesk
Earnings Scheduled For February 4, 2025
Benzinga Insights
Monday, February 03, 2025
Share of health insurers are trading higher a...
Benzinga Newsdesk
Wednesday, January 29, 2025
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Anthony Noto
Tuesday, January 21, 2025
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today
Benzinga Insights
Watching Centene; Traders Circulate Unconfirm...
Benzinga Newsdesk
Thursday, January 16, 2025
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?
Vaishali Prayag
Shares of insurers and pharmacy benefit manag...
Benzinga Newsdesk
Monday, January 13, 2025
Shares of health insurers are trading higher ...
Benzinga Newsdesk
Friday, December 27, 2024
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Benzinga Insights
Friday, December 20, 2024
(CNC) - Analyzing Centene's Short Interest
Benzinga Insights
Thursday, December 19, 2024
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh
Here's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
Benzinga Insights
Tuesday, December 17, 2024
JP Morgan Assumes Centene at Overweight, Lowe...
Benzinga Newsdesk
Friday, December 13, 2024
Centene shares are trading higher after the U...
Benzinga Newsdesk
Stephens & Co. Maintains Equal-Weight on Cent...
Benzinga Newsdesk
Truist Securities Maintains Buy on Centene, L...
Benzinga Newsdesk
Barclays Maintains Overweight on Centene, Rai...
Benzinga Newsdesk
This PayPal Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Avi Kapoor
Oppenheimer Maintains Outperform on Centene, ...
Benzinga Newsdesk
UBS Upgrades Centene to Buy, Raises Price Tar...
Benzinga Newsdesk
Thursday, December 12, 2024
C-Suite Buy of the Week: Executives' Investments Offer Clues to Market Directions
Tim Melvin
Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
Vandana Singh
Centene Exec Says Co Would "Love To Responsib...
Benzinga Newsdesk
Centene Expects 2025 Total revenues Of $166.5...
Benzinga Newsdesk
Centene Expects 2025 Adjusted EPS Of Greater ...
Benzinga Newsdesk
Wednesday, December 11, 2024
Cantor Fitzgerald Reiterates Overweight on Ce...
Benzinga Newsdesk
Tuesday, December 10, 2024
$1000 Invested In Centene 20 Years Ago Would Be Worth This Much Today
Benzinga Insights
Centene Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Benzinga Insights
Centene shares are trading lower after Jeffer...
Benzinga Newsdesk
Jefferies Downgrades Centene to Underperform,...
Benzinga Newsdesk
Wednesday, November 20, 2024
Shares of health insurance stocks are trading...
Benzinga Newsdesk
Tuesday, November 19, 2024
Looking Into Centene's Recent Short Interest
Benzinga Insights
Wednesday, November 13, 2024
Centene Plans To Reaffirm 2024 Adjusted EPS G...
Benzinga Newsdesk
Saturday, November 09, 2024
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Vandana Singh
Tuesday, November 05, 2024
(CNC) - Analyzing Centene's Short Interest
Benzinga Insights
Monday, November 04, 2024
Wells Fargo Maintains Overweight on Centene, ...
Benzinga Newsdesk
Friday, November 01, 2024
Centene's Buckeye Health Plan Awarded Contrac...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch